{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:21:30Z","timestamp":1790785290333,"version":"4.1.0"},"reference-count":98,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T00:00:00Z","timestamp":1549411200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2019.00068","type":"journal-article","created":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T04:24:42Z","timestamp":1549427082000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":45,"title":["Diagnostic Challenge and Neuromuscular Junction Contribution to ALS Pathogenesis"],"prefix":"10.3389","volume":"10","author":[{"given":"Maria-Letizia","family":"Campanari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annis-Rayan","family":"Bourefis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edor","family":"Kabashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,2,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1136\/jnnp.2009.183525","article-title":"Incidence of amyotrophic lateral sclerosis in Europe","volume":"81","author":"Logroscino","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B2","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3109\/17482960802566824","article-title":"Prognostic factors in ALS: a critical review","volume":"10","author":"Chi\u00f2","year":"2009","journal-title":"Amyotroph Lateral Scler."},{"key":"B3","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/S0140-6736(10)61156-7","article-title":"Amyotrophic lateral sclerosis","volume":"377","author":"Kiernan","year":"2011","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1212\/01.wnl.0000200048.53766.b4","article-title":"A locus on chromosome 9p confers susceptibility to ALS and frontotemporal dementia","volume":"66","author":"Morita","year":"2006","journal-title":"Neurology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1093\/brain\/awl030","article-title":"Familial amyotrophic lateral sclerosis with frontotemporal dementia is linked to a locus on chromosome 9p13.2-21.3","volume":"129","author":"Vance","year":"2006","journal-title":"Brain"},{"key":"B6","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nrn3430","article-title":"The changing scene of amyotrophic lateral sclerosis","volume":"14","author":"Robberecht","year":"2013","journal-title":"Nat Rev Neurosci."},{"key":"B7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1017\/S0317167100031280","article-title":"Familial amyotrophic lateral sclerosis, 1850-1989 : a statistical analysis of the world literature","volume":"18","author":"Strong","year":"1991","journal-title":"Can J Neurol Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1056\/NEJMra1603471","article-title":"Amyotrophic lateral sclerosis","volume":"377","author":"Brown","year":"2017","journal-title":"N Engl J Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/nn.4000","article-title":"Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia","volume":"18","author":"Freischmidt","year":"2015","journal-title":"Nat Neurosci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e28","DOI":"10.1093\/brain\/aww033","article-title":"NEK1 mutations in familial amyotrophic lateral sclerosis","volume":"139","author":"Brenner","year":"2016","journal-title":"Brain"},{"key":"B11","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.neuron.2017.07.025","article-title":"TIA1 mutations in amyotrophic lateral sclerosis and frontotemporal dementia promote phase separation and alter stress granule dynamics","volume":"95","author":"Mackenzie","year":"2017","journal-title":"Neuron"},{"key":"B12","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/362059a0","article-title":"Mutations in Cu\/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis","volume":"362","author":"Rosen","year":"1993","journal-title":"Nature"},{"key":"B13","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.neuron.2011.09.010","article-title":"A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD","volume":"72","author":"Renton","year":"2011","journal-title":"Neuron"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1126\/science.1154584","article-title":"TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis","volume":"319","author":"Sreedharan","year":"2008","journal-title":"Science"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1126\/science.1166066","article-title":"Mutations in the FUS\/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis","volume":"547","author":"Kwiatkowski","year":"2009","journal-title":"Science"},{"key":"B16","doi-asserted-by":"publisher","first-page":"442","DOI":"10.3389\/fnins.2017.00442","article-title":"The enigmatic role of C9ORF72 in autophagy","volume":"11","author":"Nassif","year":"2017","journal-title":"Front Neurosci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1177\/1073858414561795","article-title":"SOD1 Function and its implications for amyotrophic lateral sclerosis pathology: new and renascent themes","volume":"21","author":"Bunton-Stasyshyn","year":"2015","journal-title":"Neuroscientist"},{"key":"B18","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.pneurobio.2016.09.004","article-title":"TDP-43\/FUS in motor neuron disease: complexity and challenges","author":"Guerrero","year":"2016","journal-title":"Prog Neurobiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1007\/s12031-010-9467-1","article-title":"The \u2018dying-back' phenomenon of motor neurons in ALS","volume":"43","author":"Dadon-Nachum","year":"2011","journal-title":"J Mol Neurosci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3389\/fnmol.2016.00160","article-title":"Neuromuscular junction impairment in amyotrophic lateral sclerosis: reassessing the role of acetylcholinesterase","volume":"9","author":"Campanari","year":"2016","journal-title":"Front Mol Neurosci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"E2092","DOI":"10.3390\/ijms18102092","article-title":"Neuromuscular junction dismantling in amyotrophic lateral sclerosis","volume":"18","author":"Cappello","year":"2017","journal-title":"Int J Mol Sci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.coph.2009.03.007","article-title":"Neuromuscular junction destruction during amyotrophic lateral sclerosis: insights from transgenic models","volume":"9","author":"Dupuis","year":"2009","journal-title":"Curr Opin Pharmacol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.expneurol.2003.10.004","article-title":"Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man","volume":"185","author":"Fischer","year":"2004","journal-title":"Exp Neurol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1523\/JNEUROSCI.20-07-02534.2000","article-title":"Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases","volume":"20","author":"Frey","year":"2000","journal-title":"J Neurosci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/ana.20420","article-title":"Nogo expression in muscle correlates with amyotrophic lateral sclerosis severity","volume":"57","author":"Jokic","year":"2005","journal-title":"Ann Neurol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1002\/acn3.179","article-title":"Endplate denervation correlates with Nogo-A muscle expression in amyotrophic lateral sclerosis patients","volume":"2","author":"Bruneteau","year":"2015","journal-title":"Ann Clin Transl Neurol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1038\/sj.embor.7400826","article-title":"The neurite outgrowth inhibitor Nogo-A promotes denervation in an amyotrophic lateral sclerosis model","volume":"7","author":"Jokic","year":"2006","journal-title":"EMBO Rep."},{"key":"B28","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jchemneu.2016.03.003","article-title":"Axonal degeneration, distal collateral branching and neuromuscular junction architecture alterations occur prior to symptom onset in the SOD1 G93A mouse model of amyotrophic lateral sclerosis","volume":"76","author":"Clark","year":"2016","journal-title":"J Chem Neuroanat."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/j.febslet.2009.04.019","article-title":"Depletion of TDP-43 affects Drosophila motoneurons terminal synapsis and locomotive behavior","volume":"583","author":"Feiguin","year":"2009","journal-title":"FEBS Lett."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1093\/hmg\/ddt005","article-title":"Loss and gain of Drosophila TDP-43 impair synaptic efficacy and motor control leading to age-related neurodegeneration by loss-of-function phenotypes","volume":"22","author":"Diaper","year":"2013","journal-title":"Hum Mol Genet."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e39483","DOI":"10.1371\/journal.pone.0039483","article-title":"Knockdown of the Drosophila fused in sarcoma (FUS) homologue causes deficient locomotive behavior and shortening of motoneuron terminal branches","volume":"7","author":"Sasayama","year":"2012","journal-title":"PLoS ONE"},{"key":"B32","doi-asserted-by":"publisher","first-page":"3810","DOI":"10.1093\/hmg\/ddu094","article-title":"The ALS gene FUS regulates synaptic transmission at the Drosophila neuromuscular junction","volume":"23","author":"Machamer","year":"2014","journal-title":"Hum Mol Genet."},{"key":"B33","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1093\/hmg\/ddp534","article-title":"Gain and loss of function of ALS-related mutations of TARDBP (TDP-43) cause motor deficits in vivo","volume":"19","author":"Kabashi","year":"2009","journal-title":"Hum Mol Genet."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e1002214","DOI":"10.1371\/journal.pgen.1002214","article-title":"Fus and tardbp but not sod1 interact in genetic models of amyotrophic lateral sclerosis","volume":"7","author":"Kabashi","year":"2011","journal-title":"PLoS Genet."},{"key":"B35","doi-asserted-by":"publisher","first-page":"4282","DOI":"10.1093\/hmg\/ddt278","article-title":"Loss and gain of FUS function impair neuromuscular synaptic transmission in a genetic model of ALS","volume":"22","author":"Armstrong","year":"2013","journal-title":"Hum Mol Genet."},{"key":"B36","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/ana.23946","article-title":"Loss of function of C9orf72 causes motor deficits in a zebrafish model of amyotrophic lateral sclerosis","volume":"74","author":"Ciura","year":"2013","journal-title":"Ann Neurol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1242\/dmm.029058","article-title":"Modelling amyotrophic lateral sclerosis: progress and possibilities","volume":"10","author":"Van","year":"2017","journal-title":"Dis Model Mech."},{"key":"B38","first-page":"85","article-title":"Amyotrophic lateral sclerosis mimic syndromes","volume":"15","author":"Ghasemi","year":"2016","journal-title":"Iran J Neurol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1001\/archneur.57.1.109","article-title":"Amyotrophic lateral sclerosis mimic syndromes","volume":"57","author":"Traynor","year":"2000","journal-title":"Arch Neurol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1080\/146608200300079536","article-title":"El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis","volume":"1","author":"Brooks","year":"2000","journal-title":"Amyotroph Lateral Scler."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/S0022-510X(99)00209-9","article-title":"Consensus guidelines for the design and implementation of clinical trials in ALS. World Federation of Neurology committee on Research","volume":"169","author":"Miller","year":"1999","journal-title":"J Neurol Sci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1001\/archneur.57.8.1171","article-title":"Clinical features of amyotrophic lateral sclerosis according to the El Escorial and airlie house diagnostic criteria","volume":"57","author":"Traynor","year":"2000","journal-title":"Arch. Neurol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1080\/17482960802521126","article-title":"Awaji diagnostic algorithm increases sensitivity of El Escorial criteria for ALS diagnosis","volume":"10","author":"De","year":"2009","journal-title":"Amyotroph Lateral Scler."},{"key":"B44","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/brain\/118.3.707","article-title":"Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction","volume":"118","author":"Haverkamp","year":"1995","journal-title":"Brain"},{"key":"B45","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/jnnp.60.2.147","article-title":"Avoiding false positive diagnoses of motor neuron disease: lessons from the Scottish Motor Neuron Disease Register","volume":"60","author":"Davenport","year":"1996","journal-title":"Neurol Neurosurg Psychiatry"},{"key":"B46","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/S0733-8619(18)31017-X","article-title":"Electrophysiologic studies in the diagnosis and prognosis of motor neuron diseases","volume":"3","author":"Daube","year":"1985","journal-title":"Neurol Clin."},{"key":"B47","doi-asserted-by":"publisher","first-page":"S89","DOI":"10.1016\/j.pmrj.2013.03.020","article-title":"Electrodiagnosis in persons with amyotrophic lateral sclerosis","volume":"5","author":"Joyce","year":"2013","journal-title":"PM R"},{"key":"B48","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.pmr.2012.08.022","article-title":"Electrodiagnosis of motor neuron disease","volume":"24","author":"Duleep","year":"2013","journal-title":"Phys Med Rehabil Clin N Am"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1016\/j.clinph.2006.03.002","article-title":"F wave study in amyotrophic lateral sclerosis: assessment of balance between upper and lower motor neuron involvement","volume":"117","author":"Argyriou","year":"2006","journal-title":"Clin Neurophysiol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/(SICI)1097-4598(200003)23:3<344::AID-MUS5>3.0.CO;2-N","article-title":"Nerve conduction studies in amyotrophic lateral sclerosis","volume":"23","author":"de Carvalho","year":"2000","journal-title":"Muscle Nerve"},{"key":"B51","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1111\/j.1468-1331.2010.02951.x","article-title":"EFNS guidelines on the use of neuroimaging in the management of motor neuron diseases","volume":"17","author":"Filippi","year":"2010","journal-title":"Eur J Neurol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1517\/17530059.2010.536836","article-title":"Advances in the application of MRI to amyotrophic lateral sclerosis","volume":"4","author":"Turner","year":"2010","journal-title":"Expert Opin Med Diagn."},{"key":"B53","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/mus.24630","article-title":"Magnetic resonance imaging abnormalities of peripheral nerve and muscle are common in amyotrophic lateral sclerosis and share features with multifocal motor neuropathy","volume":"52","author":"Staff","year":"2015","journal-title":"Muscle Nerve"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1001\/jamaneurol.2014.1129","article-title":"Amyotrophic lateral sclerosis outcome measures and the role of albumin and creatinine","volume":"71","author":"Chi\u00f2","year":"2014","journal-title":"JAMA Neurol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1212\/01.wnl.0000285080.70324.27","article-title":"Dyslipidemia is a protective factor in amyotrophic lateral sclerosis","volume":"70","author":"Dupuis","year":"2008","journal-title":"Neurology"},{"key":"B56","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s00415-010-5805-z","article-title":"Patients with elevated triglyceride and cholesterol serum levels have a prolonged survival in amyotrophic lateral sclerosis","volume":"258","author":"Dorst","year":"2011","journal-title":"J Neurol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jns.2009.06.002","article-title":"Low uric acid levels in serum of patients with ALS: Further evidence for oxidative stress?","volume":"285","author":"Keizman","year":"2009","journal-title":"J Neurol Sci."},{"key":"B58","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2174\/1874205X00802010051","article-title":"Serum ferritin and metal levels as risk factors for amyotrophic lateral sclerosis","volume":"2","author":"Qureshi","year":"2008","journal-title":"Open Neurol J."},{"key":"B59","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s00726-002-0352-2","article-title":"Plasma amino acids concentration in amyotrophic lateral sclerosis patients","volume":"25","author":"Ilzecka","year":"2003","journal-title":"Amino Acids"},{"key":"B60","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0022-510X(01)00514-7","article-title":"Increased interleukin-6 of skin and serum in amyotrophic lateral sclerosis","volume":"187","author":"Ono","year":"2001","journal-title":"J Neurol Sci."},{"key":"B61","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/mus.880040108","article-title":"Plasma and red blood cell acetylcholinesterase in amyotrophic lateral sclerosis","volume":"4","author":"Festoff","year":"1981","journal-title":"Muscle Nerve"},{"key":"B62","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/j.1468-1331.2009.02775.x","article-title":"Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis","volume":"17","author":"Niebroj-Dobosz","year":"2010","journal-title":"Eur J Neurol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1080\/14789450.2017.1365602","article-title":"Proteomic studies in the discovery of cerebrospinal fluid biomarkers for amyotrophic lateral sclerosis","volume":"14","author":"Barschke","year":"2017","journal-title":"Expert Rev Proteomics"},{"key":"B64","doi-asserted-by":"publisher","first-page":"S61","DOI":"10.1080\/14660820050515773-1","article-title":"Serum and cerebrospinal fluid biochemical markers of ALS","volume":"1","author":"Shaw","year":"2000","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord."},{"key":"B65","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/jcp.21208","article-title":"Signal transduction and cell-type specific regulation of matrix metalloproteinase gene expression: can MMPs be good for you?","volume":"213","author":"Vincenti","year":"2007","journal-title":"J Cell Physiol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1046\/j.1471-4159.1996.67010251.x","article-title":"Matrix metalloproteinases in the neocortex and spinal cord of amyotrophic lateral sclerosis patients","volume":"67","author":"Lim","year":"1996","journal-title":"J Neurochem."},{"key":"B67","doi-asserted-by":"publisher","first-page":"5930621","DOI":"10.1155\/2016\/5930621","article-title":"Skeletal muscle remodelling as a function of disease progression in amyotrophic lateral sclerosis","volume":"2016","author":"Jensen","year":"2016","journal-title":"Biomed Res Int."},{"key":"B68","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1002\/humu.22319","article-title":"TARDBP and FUS mutations associated with amyotrophic lateral sclerosis: summary and update","volume":"34","author":"Lattante","year":"2013","journal-title":"Hum Mutat."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1080\/15548627.2016.1189070","article-title":"The most prevalent genetic cause of ALS-FTD, C9orf72 synergizes the toxicity of ATXN2 intermediate polyglutamine repeats through the autophagy pathway","volume":"12","author":"Ciura","year":"2016","journal-title":"Autophagy"},{"key":"B70","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/gim.2016.107","article-title":"Genetic testing and genetic counseling for amyotrophic lateral sclerosis: an update for clinicians","volume":"19","author":"Roggenbuck","year":"2017","journal-title":"Genet Med."},{"key":"B71","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1212\/WNL.0000000000003686","article-title":"Genetic testing in ALS: a survey of current practices","volume":"88","author":"Vajda","year":"2017","journal-title":"Neurology"},{"key":"B72","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.ncl.2015.07.004","article-title":"Spinal muscular atrophy","volume":"33","author":"Kolb","year":"2015","journal-title":"Neurol Clin."},{"key":"B73","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nrn2670","article-title":"Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick?","volume":"10","author":"Burghes","year":"2009","journal-title":"Nat Rev Neurosci."},{"key":"B74","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/B978-0-12-803685-3.00009-4","article-title":"Motor circuit dysfunction in spinal muscular atrophy","author":"Fletcher","year":"2017","journal-title":"Spinal Muscular Atrophy."},{"key":"B75","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1006\/nbdi.1996.0010","article-title":"The Neurobiology of childhood spinal muscular atrophy","volume":"3","author":"Crawford","year":"1996","journal-title":"Neurobiol Dis."},{"key":"B76","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1007\/s13311-014-0314-x","article-title":"The genetics of spinal muscular atrophy: progress and challenges","volume":"12","author":"Farrar","year":"2015","journal-title":"Neurotherapeutics"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1093\/hmg\/11.12.1439","article-title":"Neurofilament accumulation at the motor endplate and lack of axonal sprouting in a spinal muscular atrophy mouse model","volume":"11","author":"Cifuentes-Diaz","year":"2002","journal-title":"Hum Mol Genet."},{"key":"B78","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1093\/hmg\/ddn156","article-title":"Reduced SMN protein impairs maturation of the neuromuscular junctions in mouse models of spinal muscular atrophy","volume":"17","author":"Kariya","year":"2008","journal-title":"Hum Mol Genet."},{"key":"B79","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1093\/hmg\/ddm367","article-title":"Selective vulnerability of motor neurons and dissociation of pre- and post-synaptic pathology at the neuromuscular junction in mouse models of spinal muscular atrophy","volume":"17","author":"Murray","year":"2008","journal-title":"Hum Mol Genet."},{"key":"B80","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1093\/hmg\/ddr453","article-title":"Severe neuromuscular denervation of clinically relevant muscles in a mouse model of spinal muscular atrophy","volume":"21","author":"Ling","year":"2012","journal-title":"Hum Mol Genet."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1002\/cne.23917","article-title":"Cross-disease comparison of amyotrophic lateral sclerosis and spinal muscular atrophy reveals conservation of selective vulnerability but differential neuromuscular junction pathology","volume":"524","author":"Comley","year":"2016","journal-title":"J Comp Neurol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/0022-510X(89)90059-2","article-title":"Differential diagnosis between amyotrophic lateral sclerosis and spinal muscular atrophy by skin involvement","volume":"91","author":"Ono","year":"1989","journal-title":"J Neurol Sci."},{"key":"B83","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/ana.410440216","article-title":"Nuclear inclusions of the androgen receptor protein in spinal and bulbar muscular atrophy","volume":"44","author":"Li","year":"1998","journal-title":"Ann Neurol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/S0896-6273(02)00875-9","article-title":"Androgen-dependent neurodegeneration by polyglutamine-expanded human androgen receptor in Drosophila","volume":"35","author":"Takeyama","year":"2002","journal-title":"Neuron"},{"key":"B85","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1023\/A:1005344403603","article-title":"Kennedy disease","volume":"20","author":"Fischbeck","year":"1997","journal-title":"J Inherit Metab Dis."},{"key":"B86","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4081\/ni.2013.e21","article-title":"Rapidly worsening bulbar symptoms in a patient with spinobulbar muscular atrophy","volume":"5","author":"Diaz-Abad","year":"2013","journal-title":"Neurol Int."},{"key":"B87","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/0022-510X(95)00284-9","article-title":"Spinal and bulbar muscular atrophy: androgen receptor dysfunction caused by a trinucleotide repeat expansion","volume":"135","author":"MacLean","year":"1996","journal-title":"J Neurol Sci."},{"key":"B88","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.neuron.2014.03.001","article-title":"Muscle expression of mutant androgen receptor accounts for systemic and motor neuron disease phenotypes in spinal and bulbar muscular atrophy","volume":"82","author":"Cortes","year":"2014","journal-title":"Neuron"},{"key":"B89","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1007\/s00415-010-5651-z","article-title":"Myasthenia gravis: a changing pattern of incidence","volume":"257","author":"Casetta","year":"2010","journal-title":"J Neurol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3389\/fneur.2017.00218","article-title":"Amyotrophic lateral sclerosis and myasthenia gravis overlap syndrome: a review of two cases and the associated literature","volume":"8","author":"Tai","year":"2017","journal-title":"Front Neurol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/S0140-6736(86)91005-6","article-title":"False positive anti-acetylcholine receptor antibodies in motorneurone disease","volume":"1","author":"Abbott","year":"1986","journal-title":"Lancet"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/S0140-6736(86)91408-X","article-title":"False positive anti-acetylcholine receptor antibodies in motorneurone disease","volume":"1","author":"Ashizawa","year":"1986","journal-title":"Lancet"},{"key":"B93","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1177\/1756285608093888","article-title":"Progress in the treatment of myasthenia gravis","volume":"1","author":"Gold","year":"2008","journal-title":"Ther Adv Neurol Disord."},{"key":"B94","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1007\/s13311-018-0658-8","article-title":"Inclusion body myositis: update on pathogenesis and treatment","volume":"15","author":"Naddaf","year":"2018","journal-title":"Neurotherapeutics"},{"key":"B95","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.ncl.2014.04.001","article-title":"Inclusion body myositis","volume":"32","author":"Dimachkie","year":"2014","journal-title":"Neurol Clin."},{"key":"B96","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1212\/01.wnl.0000277527.69388.fe","article-title":"Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM","volume":"70","author":"Chahin","year":"2008","journal-title":"Neurology"},{"key":"B97","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s13256-015-0647-z","article-title":"Misdiagnosis of inclusion body myositis: two case reports and a retrospective chart review","volume":"9","author":"Chilingaryan","year":"2015","journal-title":"J Med Case Rep."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1001\/archneur.58.8.1253","article-title":"Inclusion body myositis mimicking motor neuron disease","volume":"58","author":"Dabby","year":"2001","journal-title":"Arch Neurol"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2019.00068\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T04:24:44Z","timestamp":1549427084000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2019.00068\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,6]]},"references-count":98,"alternative-id":["10.3389\/fneur.2019.00068"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2019.00068","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,6]]},"article-number":"68"}}